5:20 PM
 | 
Mar 22, 2013
 |  BC Extra  |  Financial News

Cancer Genetics amends IPO again

Cancer Genetics Inc. (Rutherford, N.J.) again amended its IPO, lowering to 600,000 the number of shares it plans to sell at $10-$12....

Read the full 94 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >